Cuba is the first country in Latin America to vaccinate 80%

Cuba announced that it vaccinated 80% of its population with at least one dose of its three own immunizations: Soberana 02, Soberana Plus and Abddala, becoming the first country in Latin America to reach the goal. Since the beginning of the global health emergency, the World Health Organization (WHO) has recommended that at least 70% of the population of each country should be vaccinated to obtain the so-called “herd immunity”, which would allow the end of quarantine.

The Cuban state applied an average of 200,000 vaccines per day. The goal is to vaccinate the entire population by the end of the year, but the reopening of the borders should start in November. According to Ministry of Public Health, 64.3% of the population received the second dose and 51.3%, equivalent to 5.1 million people, completed the immunization scheme.

The data can be checked in Oxford University’s Our World in Data statistics aggregator.

In October, the Caribbean island will resume classroom classes throughout the public education system. In the last 20 days, 1.6 million children were vaccinated, with 900,000 aged between 2 and 11 years.

“Our strategy has three principles: universal, staggered and intensive vaccination. We were able to implement this strategy because Cuba has its strengths: the health system and the large pharmaceutical industry”, declared the director of science and innovation at the Ministry of Public Health of Cuba, Ileana Morales.

All Cuban formulas went through clinical tests in the country and abroad until their emergency use was approved by the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed).

“We are committed to the Cuban people and what we said we are achieving,” said the director of science and innovation at the Ministry of Public Health of Cuba, Ileana Morales.

Since the beginning of the pandemic, Cuba accumulates 872,000 infected and 7,378 died by covid-19.

Edition: Thales Schmidt

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *